Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

44.06 -2.57 (-5.51%)
Official Closing Price Updated: 7:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
46 47 Next >
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Amazon’s Healthcare Gamble: A New Era of Medical Disruption
Amazon's strategic healthcare expansion leverages technology and logistics for a potentially transformative impact on patient care and market dynamics. 
Via MarketBeat
Topics Artificial Intelligence
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
2 Telehealth Stocks That Could Gain from Trump’s New FDA Pick
Discover two telehealth stocks, Hims & Hers (HIMS) and Teladoc (TDOC), poised to benefit from Trump's FDA nominee, Dr. Marty Makary, a telemedicine advocate. 
Via MarketBeat
Topics Government Lawsuit
Where Hims & Hers Health Stands With Analysts
 
Via Benzinga
Exploring growth characteristics of HIMS & HERS HEALTH INC (NYSE:HIMS).
Should you consider HIMS & HERS HEALTH INC (NYSE:HIMS) for growth investing? 
Via Chartmill
The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market
An age-old battle in pharmaceuticals could further rattle Eli Lilly stock and its potential $100 billion market in obesity. 
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Hims & Hers Named to Inc.’s 2024 Best in Business List in Health Products Category
From Hims & Hers
Via Business Wire
Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
8 mid-cap stocks saw impressive gains last week. Archer, Scholar Rock, Arrowhead, Iris Energy, Hims & Hers, SoundHound, Joby Aviation, and Urban Outfitters all performed well. 
Via Benzinga
Spotlight on Hims & Hers Health: Analyzing the Surge in Options Activity
 
Via Benzinga
Unpacking the Latest Options Trading Trends in Hims & Hers Health
 
Via Benzinga
Price Over Earnings Overview: Hims & Hers Health
 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
Here's why Eli Lilly, Pfizer, and AstraZeneca are biotech stocks worth considering, with strong pipelines and growth potential beyond vaccines. 
Via MarketBeat
Topics Government
Why Hims & Hers Stock Jumped on Massive FDA News
Shares of Hims & Hers were on fire Monday because the FDA's new leader seems to be a fan of the company's business model. 
Via The Motley Fool
Technical Monday: A Fresh Look At The “Vanity” Trade
Nu Skin is an American multi-level marketing company for personal care products and dietary supplements. 
Via Talk Markets
Topics ETFs Stocks / Equities
Should You Buy Hims & Hers Stock on the Dip?
Via The Motley Fool
Peering Into Hims & Hers Health's Recent Short Interest
 
Via Benzinga
What's Going On With Hims & Hers Health Stock Monday?
Shares of Hims & Hers Health, Inc. (NYSE: HIMS) traded higher on Monday in response to President-elect Donald Trump's plans to nominate Marty Makary to lead the Food and Drug Administration (FDA).... 
Via Benzinga
Topics Government
BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday
 
Via Benzinga
Applied Digital And Hims & Hers Health Are Among Top 9 Mid-Cap Gainers Last Week (Nov 18-Nov 22): Are The Others In Your Portfolio?
The top performers in the last week were Lemonade, Inc., Archer Aviation Inc., C3.ai, Inc., Oklo Inc., Applied Digital Corporation, Unity Software Inc., Nebius Group N.V., NuScale Power Corporation,... 
Via Benzinga
Hims & Hers New Growth Category Is a Huge Surprise
Is the food business the right business for Hims & Hers to be in? 
Via The Motley Fool
Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys
From Hims & Hers
Via Business Wire
Amazon Sets Sights on Both Hims & Hers and Temu. Is This a Golden Opportunity to Buy the Stock?
Via The Motley Fool
Guardant Health Stock Sees RS Rating Jump To 83
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. 
Via Investor's Business Daily
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
From Hims & Hers
Via Business Wire
Wall Street's Top 10 Stock Calls This Week - Saturday, Nov. 16
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Nov. 11-15, 2024. 
Via Talk Markets
Hims & Hers Stock Is Down 30% This Week: Here's What Happened
Hims & Hers has given back recent gains, but don't overlook the company's massive growth. 
Via The Motley Fool
From Volatility To Opportunity: Key Stocks Poised To Shine Today
Volatile market? Learn how RCAT, ROOT, and GEO stand out with robust catalysts, sentiment, and fundamentals. 
Via Talk Markets
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
46 47 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.